Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2014-10-15
|
| gptkbp:ATCCode |
gptkb:L04AX05
|
| gptkbp:CASNumber |
gptkb:53179-13-8
|
| gptkbp:form |
gptkb:tablet
capsule |
| gptkbp:genericName |
gptkb:pirfenidone
|
| https://www.w3.org/2000/01/rdf-schema#label |
Esbriet
|
| gptkbp:indication |
idiopathic pulmonary fibrosis
|
| gptkbp:KEGGID |
D08323
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Genentech
gptkb:Roche |
| gptkbp:mechanismOfAction |
anti-inflammatory
antifibrotic |
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:prescriptionStatus |
Rx only
|
| gptkbp:PubChem_CID |
gptkb:DB04951
gptkb:CHEMBL1201197 40632 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea fatigue rash photosensitivity |
| gptkbp:UNII |
8Z5Z9P6X8W
|
| gptkbp:usedFor |
idiopathic pulmonary fibrosis
|
| gptkbp:bfsParent |
gptkb:Roche
|
| gptkbp:bfsLayer |
6
|